🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
For most breast cancer patients, surgery is the primary treatment. When pat...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2015-06
Trial ID
NCT02438358
Treatments Being Tested
This single-site, non-randomized, open-label study to assess the initial sa...
Status
Withdrawn
Location
Massachusetts General Hospital
Start Date
2026-01
Trial ID
NCT04276909
Treatments Being Tested
The objective of this feasibility study is to assess the initial safety and...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2019-03-18
Trial ID
NCT03834272
Treatments Being Tested
The overall objective of this study is to assess the safety and efficacy of...
Status
Terminated
Location
Brigham and Women's Hospital
Start Date
2019-05-03
Trial ID
NCT03717142
Treatments Being Tested
This is a non-randomized, open-label, multi-site study to collect safety an...
Status
Completed
Location
University of South Alabama
Start Date
2018-02-06
Trial ID
NCT03321929
Treatments Being Tested
The overall goal of this feasibility study is to assess the initial safety ...
Status
Recruiting
Location
Massachusetts General Hospital
Start Date
2016-08-04
Trial ID
NCT02584244
Treatments Being Tested
The primary objective of this feasibility study is to determine if administ...
Status
Terminated
Location
Icahn School of Medicine at Mount Sinai
Start Date
2019-03-20
Trial ID
NCT03441464
Treatments Being Tested
This is a prospective, multi-center, randomized, clinical trial evaluating ...
Status
Terminated
Location
Stanford Hospital and Clinics
Start Date
2020-09-01
Trial ID
NCT04440982
Treatments Being Tested
This is a multi-center, two-arm randomized, blinded pivotal study to demons...
Status
Completed
Location
University of South Alabama Mitchell Cancer Institute
Start Date
2019-11-04
Trial ID
NCT03686215
Treatments Being Tested